ATE307340T1 - Verfahren für die feststellung von asthma suszeptibilität - Google Patents
Verfahren für die feststellung von asthma suszeptibilitätInfo
- Publication number
- ATE307340T1 ATE307340T1 AT99968477T AT99968477T ATE307340T1 AT E307340 T1 ATE307340 T1 AT E307340T1 AT 99968477 T AT99968477 T AT 99968477T AT 99968477 T AT99968477 T AT 99968477T AT E307340 T1 ATE307340 T1 AT E307340T1
- Authority
- AT
- Austria
- Prior art keywords
- asthma
- asthma susceptibility
- severity
- disclosed
- determining whether
- Prior art date
Links
- 208000006673 asthma Diseases 0.000 title abstract 5
- 102000010787 Interleukin-4 Receptors Human genes 0.000 abstract 1
- 108010038486 Interleukin-4 Receptors Proteins 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 230000011664 signaling Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6884—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from lung
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/5406—IL-4
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/12—Pulmonary diseases
- G01N2800/122—Chronic or obstructive airway disorders, e.g. asthma COPD
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11193698P | 1998-12-11 | 1998-12-11 | |
| PCT/US1999/029417 WO2000034789A2 (en) | 1998-12-11 | 1999-12-10 | Method for determining asthma susceptibility |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE307340T1 true ATE307340T1 (de) | 2005-11-15 |
Family
ID=22341233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99968477T ATE307340T1 (de) | 1998-12-11 | 1999-12-10 | Verfahren für die feststellung von asthma suszeptibilität |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6379890B1 (de) |
| EP (1) | EP1137947B1 (de) |
| JP (1) | JP2002532073A (de) |
| AT (1) | ATE307340T1 (de) |
| AU (1) | AU2588600A (de) |
| CA (1) | CA2354673A1 (de) |
| DE (1) | DE69927846T2 (de) |
| ES (1) | ES2249061T3 (de) |
| WO (1) | WO2000034789A2 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0021484D0 (en) * | 2000-09-01 | 2000-10-18 | Boehringer Ingelheim Pharma | Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
| US7208579B2 (en) * | 2003-05-30 | 2007-04-24 | The Regents Of The University Of California | IL4 receptor antagonists for horse, dog and cat |
| US7732135B2 (en) | 2003-08-05 | 2010-06-08 | Hershey Gurjit K Khurana | Genetic markers of food allergy |
| AU2006216514C1 (en) | 2005-02-25 | 2012-09-27 | Isis Pharmaceuticals, Inc. | Compositions and their uses directed to IL-4R alpha |
| JP2009510174A (ja) * | 2005-10-03 | 2009-03-12 | アイシス ファーマシューティカルズ, インコーポレーテッド | ブデソニドおよびil−4受容体アルファを標的化するアンチセンスオリゴヌクレオチドを用いた併用療法 |
| CA2625446A1 (en) * | 2005-10-13 | 2007-04-19 | Friedrich-Alexander-Universitaet Erlangen-Nuernberg | Means and methods for the prediction of joint destruction |
| US7378717B2 (en) * | 2005-11-15 | 2008-05-27 | International Business Machines Corporation | Semiconductor optical sensors |
| US20070270366A1 (en) * | 2005-12-20 | 2007-11-22 | Karras James G | Double stranded nucleic acid molecules targeted to il-4 receptor alpha |
| EP2076777A4 (de) * | 2006-09-28 | 2009-12-30 | Centocor Ortho Biotech Inc | Verfahren zur erkennung von il-16-aktivität und modulation von il-16-aktivität auf basis der proxy-konzentrationen von phosphoryliertem stat6 |
| EP2141499A1 (de) * | 2008-07-02 | 2010-01-06 | Apoptec AG | COPD-Diagnose |
| EP2414520A2 (de) | 2009-03-31 | 2012-02-08 | Altair Therapeutics, Inc. | Verfahren zur modulation einer immunantwort auf eine virusinfektion |
| US20220033489A1 (en) * | 2018-12-04 | 2022-02-03 | The Children's Medical Center Corporation | Methods and compositions for treating asthma |
| WO2021161997A1 (ja) * | 2020-02-10 | 2021-08-19 | 国立大学法人山口大学 | ヒトインターロイキン4受容体の変異ポリペプチド、及びm2マクロファージへの分化又は分極誘導剤 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5654139A (en) * | 1994-09-21 | 1997-08-05 | The United States Of America As Represented By The Department Of Health And Human Services | Allelic variation of the serotonin 5HT2c receptor |
| JPH11332567A (ja) * | 1998-05-22 | 1999-12-07 | Dai Ichi Seiyaku Co Ltd | アトピー体質の判定方法 |
-
1999
- 1999-12-10 DE DE69927846T patent/DE69927846T2/de not_active Expired - Fee Related
- 1999-12-10 WO PCT/US1999/029417 patent/WO2000034789A2/en not_active Ceased
- 1999-12-10 JP JP2000587192A patent/JP2002532073A/ja active Pending
- 1999-12-10 EP EP99968477A patent/EP1137947B1/de not_active Expired - Lifetime
- 1999-12-10 CA CA002354673A patent/CA2354673A1/en not_active Abandoned
- 1999-12-10 AT AT99968477T patent/ATE307340T1/de not_active IP Right Cessation
- 1999-12-10 AU AU25886/00A patent/AU2588600A/en not_active Abandoned
- 1999-12-10 ES ES99968477T patent/ES2249061T3/es not_active Expired - Lifetime
- 1999-12-10 US US09/459,158 patent/US6379890B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69927846T2 (de) | 2006-07-13 |
| EP1137947A2 (de) | 2001-10-04 |
| WO2000034789A2 (en) | 2000-06-15 |
| EP1137947B1 (de) | 2005-10-19 |
| JP2002532073A (ja) | 2002-10-02 |
| ES2249061T3 (es) | 2006-03-16 |
| DE69927846D1 (de) | 2006-03-02 |
| AU2588600A (en) | 2000-06-26 |
| US6379890B1 (en) | 2002-04-30 |
| WO2000034789A3 (en) | 2000-09-08 |
| CA2354673A1 (en) | 2000-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69927846D1 (de) | Verfahren für die feststellung von asthma suszeptibilität | |
| DE69925625D1 (de) | Verfahren und vorrichtung zum vorhersagen von menschlichen kognitiven leistung | |
| DE69920006D1 (de) | Verfahren und vorrichtung für elektrochemische messungen unter verwendung von statistischen methoden | |
| CA2316361A1 (en) | A method for predicting an abnormal level of clotting proteins | |
| ES2164888T3 (es) | Un metodo y un aparato para predecir la presencia de desequilibrios congenitos y adquiridos y estados terapeuticos. | |
| ATE302976T1 (de) | Anlage und verfahren zum vorhersagen von menschlichen kognitiven leistungen unter verwendung von aktigraphdaten | |
| ATE339196T1 (de) | Zelladhäsionsinhibitoren | |
| ATE402518T1 (de) | Verfahren zum bestimmen eines numerischen wertes für die zeitliche dauer eines sich periodisch wiederholenden impulsförmigen signals, und vorrichtung zur durchführung eines solchen verfahrens | |
| ATE447878T1 (de) | Verfahren und vorrichtung zur augenverfolgung | |
| ATE334445T1 (de) | Verfahren, vorrichtung, medium und programm zur aufnahme und zum verlassen von mehreren fäden in einem vielfadenprozessor | |
| DE10196984T1 (de) | Verfahren und System für die Vorhersage von Ursachen von Netzwerk-Service-Ausfällen unter Benutzung der Zeit-Domänen Korrelation | |
| DE69531077D1 (de) | Verfahren und Vorrichtung mit Benutzereinwirkung der Art Erproben-und-Kaufen, die es ermöglicht, Software zu erproben | |
| ATE476719T1 (de) | Verhaltensbasierte anpassung von computersystemen | |
| ATE277401T1 (de) | Vorrichtung und verfahren zur erkennung von gefühlen in der menschlichen stimme | |
| IT1208769B (it) | Teristiche varianti nel tempo procedimento e dispositivo per la cancellazione numerica dell eco generato in collegamenti con carat | |
| DE59915174D1 (de) | Verfahren und vorrichtung zum ermitteln der temper | |
| ATE514297T1 (de) | Verfahren und system zur bereitstellung eines einzigen ruhestellungs-/messanforderungselements für vereinte kanäle in einem drahtlosen lokalen netzwerk gemäss 802.11 | |
| ATE404118T1 (de) | System für kontinuierliche leistungstests | |
| DE69621499D1 (de) | Kalkulator zur Abschätzung der Maximalwahrscheinlichkeits-Abfolge und Verfahren hierfür | |
| DE69725606D1 (de) | Methoden für die diagnose von allergischen atemwegsaspergillosen | |
| DE60309453D1 (de) | Vorrichtung zur verwaltung von einem patientenbehandlungsprogramm | |
| GB2349476A (en) | Assessment of corrosion | |
| BR0015171A (pt) | Aparelho e método para análise de dados de performance e de falha | |
| ATE186121T1 (de) | Verfahren zur bestimmung des präthrombotischen status | |
| ATE394360T1 (de) | Verfahren zur verminderung von von der verwendung von fluorphosphitkatalysatoren herruehrenden fluoridverunreinigungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1137947 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |